Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Common Stock Shares Outstanding of 12.79 million shares for the year ending 2025.
- Tonix Pharmaceuticals Holding Corp. showed a decrease of -97.7% in Common Stock Shares Outstanding from 2025 to 2025.
- This data is from Tonix Pharmaceuticals Holding Corp.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 20 years of available data (2010 to 2025), Tonix Pharmaceuticals Holding Corp.'s Common Stock Shares Outstanding has declined by 29.1%.
- Historical annual values: Fiscal year 2025: 12.79 million shares | Fiscal year 2025: 559.04 million shares | Fiscal year 2024: 4.39 million shares | Fiscal year 2024: 95.54 million shares | Fiscal year 2023: 20,926 shares | Fiscal year 2022: 12.37 million shares | Fiscal year 2021: 15.64 million shares | Fiscal year 2020: 206.01 million shares | Fiscal year 2019: 8.53 million shares | Fiscal year 2019: 15.72 million shares | Fiscal year 2018: 328,689 shares | Fiscal year 2018: 1.53 million shares | Fiscal year 2017: 7.83 million shares | Fiscal year 2016: 3.92 million shares | Fiscal year 2015: 1.88 million shares | Fiscal year 2014: 10.81 million shares | Fiscal year 2013: 5.82 million shares | Fiscal year 2012: 2.16 million shares | Fiscal year 2011: 27.07 million shares | Fiscal year 2010: 18.03 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: